1. Influenza Transmission in Experimental and Field Settings - Hui-Ling Yen (University of Hong Kong)                        

2. Pathogenesis and Transmission of Emerging Influenza Viruses - Sander Herfst [Erasmus MC, Netherlands]

2 Shifting the Diagnostic Paradigm from Pathogen to Host - Ann Falsey (University of Rochester, USA)

2. Impact on cardiovascular outcomes - Jeff Kwong (ICES, Canada)

3. Implications of Incomplete Viral Genomes for Influenza A Virus Fitness - Anice Lowen (Emory University, Atlanta, US)

3.Innovation in Pandemic Influenza Response - Rick Bright (US Dept. of Health and Human Services, USA)

Abstract No 10311: variations in seasonal influenza vaccine effectiveness due to biological characteristics: A systematic review and META-analysis of test-Negative design studies - George Okoli (University of Manitoba, Canada)

Abstract No 10440: Autophagy-mediated restriction of avian influenza virus replication in mammalian cell - Siwen LIU (The University of Hong Kong, Hong Kong)

Abstract No 10563: The impact of syndromic molecular point-of-care testing for respiratory viruses in adults presenting to hospital with exacerbation of airways disease: further analysis form a randomised controlled trial - Nathan Brendish (University Hospital Southampton NHS Foundation Trust, UK)

Abstract No 10395: Vaccine effectiveness against influenza hospitalization in the 2018-2019 season: comparison between cell-based and egg-based influenza vaccines – Hung Fu Tseng (Kasier Permanente Southern California, USA)

Abstract No 10855: Haemagglutinin mutation and higher neuraminidase activity enhanced the adaption of H5N6 avian influenza viruses to mammalian hosts - Honglei Sun (China Agricultural University, People’s Republic of China)

Abstract No 10565: Evaluation of the Febridx host response point-of-care test to differentiate viral from bacterial aetiology in adults hospitalised with acute respiratory illness during influenza season - Nathan Brendish (University Hospital Southampton NHS Foundation Trust, UK)

Abstract No 10881: Influenza vaccine effectiveness against laboratory-confirmed influenza mortality in older adults – Jeff Kwong (ICES, Canada)

Abstract No 10499: Relative vaccine effectiveness of high dose versus adjuvanted influenza vaccine: a retrospective cohort study - Robertus van Aalst  (Sanofi Pasteur, USA)

Abstract No 10877: Rapid molecular testing for influenza in children improves patient management in acute care setting – Rangaraj Selvarangan (Childrens MercyHospital, USA)

Abstract No 10750: Seasonal and other influenza viruses with reduced susceptibility to Baloxavir and Pimodivir  - Larisa Gubareva (CDC, USA)

Abstract No 10904: Evaluating the window of susceptibility to secondary bacterial infections post-influenza infection in ferrets - Edin Mifsud (Peter Doherty Institute, Australia)

1 Forecasting Seasonal Influenza Activity - Jeff Shaman (Columbia University, USA)

Abstract No 11089: Influenza a virus surface proteins are organized to help penetrate host mucus – Michael Vahey (Washington University in St. Louis, USA)

Abstract No 10964: Seasonal H1N1 and antigenically drifted H3N2 influenza viruses that have limited binding to sialic acid bind to phosphorylated high mannose glycans from the human lung - Lauren Byrd-Leotis (Harvard Medical School, USA)

Abstract No 10900: Neuraminidase-targeted hapten immunotherapy to treat influenza -  Xin Liu (Purdue University, USA)

1 The Influenza Virus Neuraminidase as a Vaccine Target - Florian Krammer (Icahn School of Medicine USA)

1 Adjuvant Therapy for Severe Influenza Infection - Ivan Hung (University of Hong Kong)

1 Strategies to Enhance Local Protective Influenza-Specific Immunity in the Respiratory Tract - Andrea Sant (University of Rochester Medical Center, USA)

Abstract No 11170: Characterising human memory B cells with cross-lineage recognition of the influenza B hemagglutinin following seasonal immmunisation - Adam Wheatley (University of Melbourne, Australia)

Abstract No 11110: Intranasal M2SR (M2-deficient single replication) influenza vaccine induced protection against challenge with a substantially drifted H3N2 virus in a phase 2 study - Joseph Eiden (FluGen, USA)

Abstract No 10535: A human broadly cross-reactive anti-neuraminidase antibody protects against different subtypes of influenza A and B viruses in the mouse model - Daniel Stadlbauer (Icahn School of Medicine at Mount Sinai, USA)

Abstract No 10475: Human-to-human transmission of influenza A(H3N2) viruses exhibiting reduced susceptibility to Baloxavir due to a PA I38T substitution in Japan – Emi Takashita (National Institute of Infectious Diseases, Japan)

Abstract No 10880: Pre-existing immunity to the conserved hemagglutinin stalk of influenza virus may drive selection for an escape mutant virus in humans - Jae-Keun Park (National Institute of Health, USA)

Abstract No 10980: RNACTIVE©: A promising mRNA based influenza vaccine - Lidia Oostvogels (CureVacAG, Germany)

1 Human CD8+ T cell cross-reactivity across Influenza A,B and C Viruses - Katherine Kedzierska (University of Melbourne, Australia)

1.Impact of Influenza Vaccination During Pregnancy on the Mother, Fetus and Infant - Marta Nunes (University of Witwatersrand, South Africa)

1 Efficacy of Live-attenuated Vaccines - Martin Friede (WHO, Switzerland)

Abstract No 10528: Annotation and recovery of ferret-specific immunoglobulin sequences - Julius Wong (University of Melbourne, Australia)

Abstract No 10490: Broadened cross-reactive immunity in ferrets after repeated influenza A/H3 exposures - Hang Xie (Center for Biologics Evaluation and Research, US Food and Drug Administration, USA)

Abstract No 10471: Molecular and functional dissection of the influenza virus-specific CD8+ T-Cell receptor repertoire during aging - Carolien van de Sandt  (The University of Melbourne at The Peter Doherty Institute, Australia)

Abstract No 11035: Innate-like signatures of influenza-specific CD8+ resident memory T cell responses in the human lung - Suzanna Paterson (Imperial College, UK)

Abstract No 11216: Subdominance and diminished tfh elicitation constrain humoral immunity against the influenza Ha-stem - Hyon-Xhi Tan (Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Australia)

Abstract No 10332: Costs and effects of childhood influenza vaccination in the Netherlands: important risk of undesirable effects - Pieter de Boer (National Institute for Public Health and the Environment, Netherlands)

1 Next Generation Orally Efficacious Influenza Drug Candidate with High Genetic Resistance Barrier - Richard Plemper (Georgia State University, USA)

1 Lessons and Experience of Clinical Diagnosis and Treatment on Avian Influenza Cases in Guangzhou, China - Zhong Nan Shan (Guangzhou Medical University, People's Republic of China)

1 Pandemic Severity Assessment - Carrie Reed (CDC, USA)

Abstract No 11313: Dissecting the mechanism of signaling-induced nuclear export of influenza virus vRNPs - Stephan Ludwig (University of Muenster, Germany)

Abstract No 10698: Differential regulation of Post-Translational Modification (PTM) status of influenza A viral Ribonucleoproteins (RNPs) during different stages of the viral life cycle - Lin Zhu (Hong Kong Baptist University, Hong Kong)

1 Immunity to Influenza in Dirty Mice - Ryan Langlios (University of Minnesota, USA)

1 Influenza in the Tropics - Lance Jennings (University of Otago, NZ)

1 Effectiveness of Influenza Vaccination in Different Populations - Brendan Flannery (CDC, USA)

3 Policy considerations for the Prevention and Control of Seasonal Influenza - Kong Insik (Ministry of Health and Welfare, Republic of Korea)

Abstract No 10428: Spatial and temporal quantification of putative lung regenerating cells during early recovery from influenza pneumonia- Joe Ong (NUS, SG)

Abstract No 11138: Obesity increases the cardiac complications of influenza virus infection - Kirsty Short (University of Queensland, Australia)

5 Panel discussion on overcoming challenges for implementation of prevention and control of seasonal influenza -

Kong Insik (Ministry of Health and Welfare, Republic of Korea)

Hongjie Yu (Fudan University, People's Republic of China)

Seng Heng (Ministry of Health, Cambodia)

Chong Chee Kheong (Ministry of Health, Malaysia)

Abstract No 11112: A history of obesity reduces the immune response to influenza virus in an NLRP3 dependent manner - Katina D. Hulme (University of Queensland, Australia)

Abstract No 10740: Repeated seasonal influenza vaccination results in reduced protection against influenza A(H3N2) infection in ferrets compared to single vaccination - Ian York (CDC,USA)

1 How Antiviral Proteins Can Stimulate Influenza Virus Replication-  Andrew Mehle (University of Wisconsin, USA)

1 Non-Pharmaceutical Public Health Measures for Mitigating the Risk and Impact of Epidemic and Pandemic Influenza - Ben Cowling (University of Hong Kong)

1: Insight into Host-pathogen Interactions in the Upper Respiratory Tract from Live-attenuated Influenza Vaccine Studies in Children- Thushan de Silva (The Gambia)

Abstract No 10606: New genomic approaches to understand the heterogeneity of viral replication in single cells - David Bacsik (Fred Hutchinson Cancer Research Center, USA)

Panel Discussion: Overcoming Challenges for Pandemic Preparedness Planning -

Supamit Chunsuttiwat (Ministry of Public Health, Republic of Korea)

Seng Heng (Ministry of Health, Cambodia)

Chong Chee Kheong (Ministry of Health, Malaysia)

Abstract No 11082: Correlates of protection for better, faster influenza vaccine development  - Armen Donabedian (US Health and Human Services, USA)

Abstract No 10943: Pre-existing NP specific T-cell response correlates with reduction of symptoms in a human Influenza challenge model  - Delphine Guyon-Gellin (Osivax, France)  and Nicolas Noulin (hVIVO, UK)

1 Mapping Selection on Influenza Virus From Polyclonal Human Serum - Jesse Bloom (Fred Hutchinson Cancer Research Center, USA)

1 REMAP-CAP: A Platform Trial to Advance Knowledge of Optimal Treatment for Critically Ill Patients with Influenza - Steve Webb (Royal Perth Hospital, Australia)

1 Influenza Burden and Links to Policy - Building the Pyramid  Cheryl Cohen (National Institute for Communicable Diseases, South Africa)

Abstract No 10822: The evolutionary dynamics of influenza A and influenza B viruses in naturally infected human hosts - Adam Lauring [University of Michigan, USA]

Abstract No 11151: Potential therapeutic role of bone marrow-derived mesenchymal stem cells in acute lung injury induced by highly pathogenic avian influenza virus A/H5N1 - Resti Yudhawati Meliana [ Airlangga University/Dr. Soetomo Hospital, Indonesia]

Abstract No 11044: The burden of in-hospital and out-of-hospital deaths among patients hospitalized with influenza, FluSurv-NET, 2010–2016 - Shikha Garg [CDC, USA

1 Ten Years After the 2009 'Swine Flu' pandemic: A Perspective from a Veterinary Biomedical Researcherv- Kristien van Reeth (Ghent University, Belgium)

1 Contagious Phenotypes of Influenza Virus Infection - Donald Milton (University of Maryland School of Public Health, USA)

1 Epidemiological Consequences of Immune Memory - Sarah Cobey (University of Chicago, USA)

2 Influenza in Context: Insights Into Universal Vaccination Against Influenza - Patrick Wilson (University of Chicago, USA)

Abstract No 10812: Reduced susceptibility viruses to baloxavir marboxil: Prognosis factors of the emergence and impact on clinical and virologic outcomes in pediatric patients in Japan – Takeki Uehara [Shionogi & Co., Ltd., Japan]

Abstract No 11198: Improving avian influenza surveillance through wetland sampling- Lauren Tindale [University of British Columbia, Canada]

Abstract No 11088: Effect of maternal pandemic vaccination on seroprevalence against influenza in children at birth and at 4 years - Anna Hayman Robertson [Norwegian Institute of Public Health, Norway]

1 Fighting Influenza from a One Health Perspective - Ab Osterhaus (TiHO, Germany)

1 Influenza Vaccination of the Immunocompromised - Deepali Kumar (University Health Network, Can)

1 Healthcare Outbreaks of Influenza - Paul Tambyah (National University of Singapore, SG)

Abstract No 10324: Vaccine induced mucosal IgA contributes to protection against influenza infection in humans -  Sean Tucker [Vaxart, Inc., USA]      

Abstract No 10448: Preliminary estimates of the incidence of influenza-associated acute respiratory infection among adults aged  >60 years in a multi-site community cohort in India – Rakesh Kumar [All India Institute of Medical Sciences, India]

Abstract No 11179: Few substitutions of H5 gene belonging to Clade 2.3.4 have altered the NA gene preferences of the virus other than N1 – Khristine Joy Antigua [Chungbuk National University, South Korea]

Abstract No 10492: Determinants of influenza transmission in households in rural North India – Aslesh Ottapura Prabhakaran [US CDC India Office, India]

Abstract No 11001: The Epidemioloogical Signature of the influenza B/Victoria and B/Yamagata Lineages in the 21st Century – John Paget [Nivel, Netherlands]